{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:09:15Z","timestamp":1778900955493,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031004","name":"KalVista Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.exer.2025.110484","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T02:42:52Z","timestamp":1749523372000},"page":"110484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The kallikrein kinin system alters neuroretinal and visual responses in mice"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5939-5754","authenticated-orcid":false,"given":"Allen","family":"Clermont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivetha","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Mao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Antonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd P.","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Feener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110484_bib1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2025.110484_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.13.18","article-title":"Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal thickening in a diabetic rat model","volume":"62","author":"Bergen","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110484_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamaophthalmol.2019.1963","article-title":"Association between change in visual acuity and change in central subfield thickness during treatment of diabetic macular edema in participants randomized to aflibercept, bevacizumab, or ranibizumab","volume":"137","author":"Bressler","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2025.110484_bib4","article-title":"Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats","volume":"1--9","author":"Clermont","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2025.110484_bib5","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1167\/iovs.15-18272","article-title":"Plasma kallikrein mediates vascular endothelial growth factor-induced retinal dysfunction and thickening","volume":"57","author":"Clermont","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110484_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1287487","article-title":"Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation","volume":"14","author":"Clermont","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2025.110484_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000438970","article-title":"Diabetic retinopathy and diabetic macular edema","volume":"55","author":"Cohen","year":"2015","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110484_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110484_bib9","doi-asserted-by":"crossref","DOI":"10.1021\/pr800112g","article-title":"Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy","author":"Gao","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.exer.2025.110484_bib10","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation","volume":"2","author":"Gao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2025.110484_bib11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2020.03.021","article-title":"Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (protocol T extension study)","volume":"127","author":"Glassman","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110484_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/biom11070988","article-title":"VEGF as a direct functional regulator of photoreceptors and contributing factor to diabetes-induced alteration of photoreceptor function","volume":"11","author":"Hu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.exer.2025.110484_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1471-4159.1996.66020676.x","article-title":"Neuroligand\u2010evoked calcium\u2010dependent release of excitatory amino acids from cultured astrocytes","volume":"66","author":"Jeftinija","year":"1996","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.exer.2025.110484_bib14","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.2337\/db15-0317","article-title":"Plasma kallikrein-kinin system as a VEGF-independent mediator of diabetic macular edema","volume":"64","author":"Kita","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2025.110484_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12886-018-0821-3","article-title":"Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2025.110484_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.lfs.2008.09.014","article-title":"Bradykinin stimulates glutamate uptake via both B1R and B2R activation in a human retinal pigment epithelial cells","volume":"83","author":"Lim","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2025.110484_bib17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1167\/iovs.18-26433","article-title":"Transducin1, phototransduction and the development of early diabetic retinopathy","volume":"60","author":"Liu","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110484_bib18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1167\/iovs.12-10537","article-title":"Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein","volume":"54","author":"Liu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110484_bib19","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1021\/acs.jproteome.5b00900","article-title":"Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients","volume":"14","author":"Loukovaara","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.exer.2025.110484_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/exer.1996.0087","article-title":"Expression and cellular localization of the kallikrein\u2013kinin system in human ocular tissues","volume":"63","author":"Ma","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110484_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1522","article-title":"Bradykinin receptor ligands: therapeutic perspectives","volume":"3","author":"Marceau","year":"2004","journal-title":"Nat Rev Drug Discov, Nature Reviews Drug Discovery"},{"key":"10.1016\/j.exer.2025.110484_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107744","article-title":"Retinal proteome associated with bradykinin-induced edema","volume":"186","author":"Murugesan","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110484_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/acschemneuro.3c00650","article-title":"The surprising nonlinear effects of S100A9 proteins in the retina","volume":"15","author":"Naaman","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.exer.2025.110484_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","article-title":"Relationship between optical coherence tomography\u2013measured central retinal thickness and visual acuity in diabetic macular edema","volume":"114","author":"Network","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110484_bib25","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ophtha.2011.09.058","article-title":"Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema","volume":"118","author":"Network","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110484_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41598-021-81540-w","article-title":"Photoperiodic regulation of dopamine signaling regulates seasonal changes in retinal photosensitivity in mice","volume":"11","author":"Okimura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2025.110484_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/ph13060130","article-title":"Differential expression of kinin receptors in human wet and dry age-related macular degeneration retinae","volume":"13","author":"Othman","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.exer.2025.110484_bib28","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/cells10081913","article-title":"Kinins and their receptors as potential therapeutic targets in retinal pathologies","volume":"10","author":"Othman","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.exer.2025.110484_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/369744a0","article-title":"Glutamate-mediated astrocyte\u2013neuron signalling","volume":"369","author":"Parpura","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exer.2025.110484_bib30","series-title":"Presented at the American Academy of Ophthalmology (AAO) 2024 Meeting, Chicago, Illinois","article-title":"Results from a phase 2A study of a novel orally administered RZ402, a plasma kallikrein inhibitor in patients with diabetic macular edema","author":"Pearlman","year":"2024"},{"key":"10.1016\/j.exer.2025.110484_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.108.117663","article-title":"Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability","author":"Phipps","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.exer.2025.110484_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1113\/jphysiol.2002.019703","article-title":"The scotopic threshold response of the dark adapted electroretinogram of the mouse","volume":"15","author":"Saszik","year":"2002","journal-title":"J Physiol Sep"},{"key":"10.1016\/j.exer.2025.110484_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2025.110484_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586013","article-title":"Influence of aging on the retina and visual motion processing for optokinetic responses in mice","volume":"14","author":"Sugita","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.exer.2025.110484_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.oret.2019.07.006","article-title":"One-time intravitreal injection of KVD001, a plasma kallikrein inhibitor, in patients with central-involved diabetic macular edema and reduced vision an open-label phase 1B study","volume":"3","author":"Sun","year":"2019","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.exer.2025.110484_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.exer.2025.110484_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109273","article-title":"Microglia depletion exacerbates retinal ganglion cell loss in a mouse model of glaucoma","volume":"225","author":"Tan","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110484_bib38","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045 systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2025.110484_bib39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.exer.2010.08.014","article-title":"Nitric oxide amplifies the rat electroretinogram","volume":"91","author":"Vielma","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110484_bib40","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1167\/iovs.02-0815","article-title":"Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotection","volume":"44","author":"Yamauchi","year":"2003","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.exer.2025.110484_bib41","first-page":"2273","article-title":"Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons","volume":"41","author":"Yasuyoshi","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:18:58Z","timestamp":1778897938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S0014483525002556"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110484","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kallikrein kinin system alters neuroretinal and visual responses in mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110484"}}